US Patent

US10603280 — Active ingredient containing stabilised solid medicinal forms and methods for the production thereof

Formulation · Assigned to Losan Pharma GmbH · Expires 2027-09-14 · 1y remaining

Vulnerability score 63/100 Moderate — design-around opportunities exist

What this patent protects

This patent protects stabilized solid medicinal forms containing at least one active ingredient and a drying agent, with specific moisture content and drying loss requirements.

USPTO Abstract

The invention relates to solid medicinal forms containing at least one active ingredient and at least one pharmaceutically compatible, water soluble drying agent which is selected from the group consisting of trimagnesium dicitrate and/or calcium chloride, the solid medicinal form having a drying loss of at most 6% and a relative equilibrium moisture content of 25% or less. The invention also relates to solid medicinal forms containing a moisture-sensitive active ingredient and trimagnesium dicitrate.

Drugs covered by this patent

Patent Metadata

Patent number
US10603280
Jurisdiction
US
Classification
Formulation
Expires
2027-09-14
Drug substance claim
No
Drug product claim
Yes
Assignee
Losan Pharma GmbH
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.